RT Journal
T1 Notes from the field: National shortage of isoniazid 300 mg tablets
JF JAMA
JO JAMA
YR 2013
FD February 20
VO 309
IS 7
SP 653
OP 653
DO 10.1001/jama.2013.223
UL http://dx.doi.org/10.1001/jama.2013.223
AB 
On November 16, 2012, the Illinois State tuberculosis (TB) program notified CDC's Division of Tuberculosis Elimination of a national shortage of 300 mg tablets of the antituberculosis medication isoniazid (INH). Subsequently, other state TB programs (e.g., California, Indiana, Maryland, New York, Virginia, and Wisconsin) reported difficulty obtaining INH 300 mg tablets. Other programs (e.g., San Diego) have experienced difficulties obtaining at least one of the commercially available anti-TB preparations containing the combination of rifampin and INH (IsonaRif [VersaPharm]).